Omega Healthcare Investors (NYSE:OHI - Get Free Report) had its price target upped by investment analysts at Wells Fargo & Company from $46.00 to $49.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an "equal weight" rating on the real estate investment trust's stock. Wells Fargo & Company's price objective suggests a potential upside of 3.16% from the stock's previous close.
Several other analysts have also issued reports on OHI. Citigroup reissued a "market outperform" rating on shares of Omega Healthcare Investors in a report on Wednesday. Barclays reduced their price target on Omega Healthcare Investors from $50.00 to $48.00 and set an "underweight" rating for the company in a research report on Tuesday, October 13th. Weiss Ratings downgraded Omega Healthcare Investors from a "buy (b+)" rating to a "buy (b)" rating in a research note on Monday, November 9th. UBS Group lifted their price objective on Omega Healthcare Investors from $52.00 to $56.00 and gave the company a "buy" rating in a research report on Wednesday, November 11th. Finally, Citizens Jmp upgraded Omega Healthcare Investors from a "market perform" rating to a "market outperform" rating and set a $52.00 price objective for the company in a research note on Thursday, October 22nd. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $50.47.
View Our Latest Report on Omega Healthcare Investors
Omega Healthcare Investors Trading Up 1.0%
OHI opened at $47.50 on Monday. The firm's 50 day simple moving average is $46.43 and its two-hundred day simple moving average is $46.79. The company has a market capitalization of $14.46 billion, a PE ratio of 19.11, a PEG ratio of 1.72 and a beta of 0.56. Omega Healthcare Investors has a 1-year low of $42.18 and a 1-year high of $52.39.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The real estate investment trust reported $0.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.20). The business had revenue of $340.55 million for the quarter, compared to the consensus estimate of $269.16 million. Omega Healthcare Investors had a net margin of 58.11% and a return on equity of 13.66%. The company's revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.79 EPS. Equities analysts forecast that Omega Healthcare Investors will post 3.12 earnings per share for the current fiscal year.
Institutional Trading of Omega Healthcare Investors
Institutional investors have recently made changes to their positions in the business. Amundi lifted its stake in shares of Omega Healthcare Investors by 100.4% during the 2nd quarter. Amundi now owns 1,125,875 shares of the real estate investment trust's stock worth $53,682,000 after acquiring an additional 564,175 shares during the last quarter. AlphaGrep UK Ltd bought a new position in Omega Healthcare Investors in the 2nd quarter valued at $1,246,000. Greenland Capital Management LP bought a new position in Omega Healthcare Investors in the 2nd quarter valued at $7,867,000. Van ECK Associates Corp grew its position in Omega Healthcare Investors by 20.0% in the 2nd quarter. Van ECK Associates Corp now owns 199,170 shares of the real estate investment trust's stock valued at $9,496,000 after acquiring an additional 33,211 shares during the last quarter. Finally, Quantinno Capital Management LP grew its position in Omega Healthcare Investors by 48.5% in the 1st quarter. Quantinno Capital Management LP now owns 2,125,931 shares of the real estate investment trust's stock valued at $93,158,000 after acquiring an additional 694,426 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.
About Omega Healthcare Investors
(
Get Free Report)
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT) focused on healthcare facilities, particularly skilled nursing and assisted living properties. The company invests in these facilities through real estate leases, loans and other financing arrangements. Its portfolio serves healthcare operators in the United States and the United Kingdom. Omega primarily leases properties to third-party operators, which manage the facilities and provide care to residents. Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega is led by President and Chief Executive Officer Taylor Pickett.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.